XSNX OTC
NovAccess Global Inc.
1W: +0.0%
1M: +0.0%
3M: +100.0%
YTD: +100.0%
1Y: -33.3%
3Y: -99.8%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000099999997-0.05
Volume55,100
Avg Volume259
Beta2.80
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODwain K. Morris-Irvin
Employees2
SectorHealthcare
IndustryBiotechnology
IPO Date1998-09-21
Websitenovaccessglobal.com
459 Columbus Avenue
New York, NY 10024
US
New York, NY 10024
US
440 644 1027
About NovAccess Global Inc.
Operating as a biopharmaceutical firm, NovAccess Global Inc. focuses on developing innovative immunotherapies to treat individuals with brain tumors across the United States. Their primary expertise is in pioneering research that leverages a patient's own immune system to target and eliminate cancerous cells. The company, founded in 1997, has its headquarters situated in Chesterland, Ohio.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| CASSARINI JOHN | A-Award | 0 | $0.11 | 2024-05-31 |
| Sumner David | 0 | — | 2024-05-17 | |
| LAIRD NEIL J | A-Award | 428,571 | $0.17 | 2023-03-13 |
| CASSARINI JOHN | A-Award | 857,143 | $0.17 | 2023-03-13 |
| Anderson Jason Micha | A-Award | 857,143 | $0.17 | 2023-03-13 |